Intellectual Property Rights (IPR)
Swadeshi Jagran Manch (SJM) offers a few comments on the opinion expressed by the 6-membered IPR Think Tank, put on public domain from December 24, 2014. Providing a selfless and tireless service to the nation by promoting ‘Swadeshi’ cause for the long term benefit of not only economy but also a cumulative betterment of socio-cultural atmosphere for decades, made us to both promote as well as object some of the findings of the IPR Think Tank.
Swiss drugmaker Novartis has locked horns with Biocon over the alleged infringement of the patent on its diabetes drug Galvus, which reportedly had global sales of over $1.2 billion last year. The legal action seeks to prevent Biocon from launching a similar version of the drug. It comes a year after a high-profile patent case involving Novartis’ blood cancer drug Glivec ended.